ConductScience.org, home

Paper266705

Synthetic peptides with the biological activities and specificity of human C3a anaphylatoxin.

Hugli TE and 1 other. Proc Natl Acad Sci U S A, 1977. Cited by 70 papers, by iCite.

Cite this record

ConductScience Library. Synthetic peptides with the biological activities and specificity of human C3a anaphylatoxin. Papers, record 266705. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/266705

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Synthetic peptides with the biological activities and specificity of human C3a anaphylatoxin.
PubMed
Journal
Proc Natl Acad Sci U S A
PubMed
Year
1977
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
70
iCite
Relative citation ratio, by iCite
1.65
iCite
Revised in PubMed
2019-05-01
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Hugli TET E
2Erickson BWB W

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AnaphylatoxinsMajor topic
Complement C3Major topic
Complement System ProteinsMajor topic
OligopeptidesMajor topic
PeptidesMajor topic
Amino Acid Sequence
Biological Assay
Capillary Permeability
Female
Ileum
Mast Cells
Muscle Contraction
Muscle, Smooth
Serotonin
Structure-Activity Relationship
Uterus

Source PubMed

Download CSV of topics

References10

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
11002996Partial characterization of human C5a anaphylatoxin. I. Chemical description of the carbohydrate and polypeptide prtions of human C5a.J Immunol1976https://conductscience.org/library/papers/1002996PubMed
2803505Purification and partial characterization of human and porcine C3a anaphylatoxin.J Biol Chem1975https://conductscience.org/library/papers/803505PubMed
34114148Cutaneous responses to human C 3 anaphylatoxin in man.Clin Exp Immunol1972https://conductscience.org/library/papers/4114148PubMed
44098172Anaphylatoxin inactivator of human plasma: its isolation and characterization as a carboxypeptidase.J Clin Invest1970https://conductscience.org/library/papers/4098172PubMed
54383923The derivation of two distinct anaphylatoxin activities from the third and fifth components of human complement.J Exp Med1968https://conductscience.org/library/papers/4383923PubMed
6234458Circular dichroism of C3a anaphylatoxin. Effects of pH, heat, guanidinium chloride, and mercaptoethanol on conformation and function.J Biol Chem1975https://conductscience.org/library/papers/234458PubMed
74708381Use of chlorinated benzyloxycarbonyl protecting groups to eliminate N -branching at lysine during solid-phase peptide synthesis.J Am Chem Soc1973https://conductscience.org/library/papers/4708381PubMed
81094920Complement.Annu Rev Biochem1975https://conductscience.org/library/papers/1094920PubMed
9956663The primary structure of porcine C3a anaphylatoxin.J Immunol1976https://conductscience.org/library/papers/956663PubMed
101238393Human anaphylatoxin (C3a) from the third component of complement. Primary structure.J Biol Chem1975https://conductscience.org/library/papers/1238393PubMed

Download CSV of references

Cited by22

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 70 citations.

PMIDTitleJournalYearIn PapersSource
40903728A Novel Class of Complement 3a Receptor Agonists and Antagonists Derived from the TLQP-21 Peptide.J Med Chem2025https://conductscience.org/library/papers/40903728PubMed
38778507Complement C3aR signaling: Immune and metabolic modulation and its impact on Alzheimer's disease.Eur J Immunol2024https://conductscience.org/library/papers/38778507PubMed
37006238Complement as a vital nexus of the pathobiological connectome for acute respiratory distress syndrome: An emerging therapeutic target.Front Immunol2023https://conductscience.org/library/papers/37006238PubMed
34395461Complement Component C3: A Novel Biomarker Participating in the Pathogenesis of Non-alcoholic Fatty Liver Disease.Front Med (Lausanne)2021https://conductscience.org/library/papers/34395461PubMed
33845430The role of human C5a as a non-genomic target in corticosteroid therapy for management of severe COVID19.Comput Biol Chem2021https://conductscience.org/library/papers/33845430PubMed
28973891Complement-activation fragment C4a mediates effector functions by binding as untethered agonist to protease-activated receptors 1 and 4.Proc Natl Acad Sci U S A2017https://conductscience.org/library/papers/28973891PubMed
28123945The neuropeptide TLQP-21 opposes obesity via C3aR1-mediated enhancement of adrenergic-induced lipolysis.Mol Metab2017https://conductscience.org/library/papers/28123945PubMed
26435769Complement activation in the context of stem cells and tissue repair.World J Stem Cells2015https://conductscience.org/library/papers/26435769PubMed
25456411The TLQP-21 peptide activates the G-protein-coupled receptor C3aR1 via a folding-upon-binding mechanism.Structure2014https://conductscience.org/library/papers/25456411PubMed
24264911Peptide-mediated behaviors in marine organisms Evidence for a common theme.J Chem Ecol1990https://conductscience.org/library/papers/24264911PubMed
7050289Modulation of human lymphocyte function by C3a and C3a(70-77).J Exp Med1982https://conductscience.org/library/papers/7050289PubMed
6978374Anaphylatoxin-mediated regulation of the immune response. I. C3a-mediated suppression of human and murine humoral immune responses.J Exp Med1982https://conductscience.org/library/papers/6978374PubMed
6977607Low zone desensitization: a stimulus-specific control mechanism of cell response. Investigations on anaphylatoxin-induced platelet secretion.J Exp Med1982https://conductscience.org/library/papers/6977607PubMed
6976935Comparative study on biological activities of various anaphylatoxins (C4a, C3a, C5a). Investigations on their ability to induce platelet secretion.Inflammation1981https://conductscience.org/library/papers/6976935PubMed
6940191Identification of classical anaphylatoxin as the des-Arg form of the C5a molecule: evidence of a modulator role for the oligosaccharide unit in human des-Arg74-C5a.Proc Natl Acad Sci U S A1981https://conductscience.org/library/papers/6940191PubMed
6387982Structure and function of the anaphylatoxins.Springer Semin Immunopathol1984https://conductscience.org/library/papers/6387982PubMed
6177210Role of histamine in the spasmogenic effect of the complement peptides C3a and C5a-desArg (classical anaphylatoxin).Agents Actions1982https://conductscience.org/library/papers/6177210PubMed
3264156Design and biological activity of a new generation of synthetic C3a analogues by combination of peptidic and non-peptidic elements.Biochem J1988https://conductscience.org/library/papers/3264156PubMed
1572104Functional activities of synthetic anaphylatoxic peptides in widely used biological assays.Clin Exp Immunol1992https://conductscience.org/library/papers/1572104PubMed
1445269A recombinant hybrid anaphylatoxin with dual C3a/C5a activity.Biochem J1992https://conductscience.org/library/papers/1445269PubMed

See all 22 cited byDownload CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
C3718PubTator's text mininghttps://conductscience.org/library/genes/718NCBI Gene
CPB11360PubTator's text mininghttps://conductscience.org/library/genes/1360NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/266705

GET https://conductscience.org/api/papers/v1/266705/cited_by?page=2